-
Views
-
Cite
Cite
S. Hiraki, I. Miyoshi, H. Masuji, I. Kubonishi, Y. Matsuda, T. Nakayama, H. Kishimoto, P. Chen, I. Kimura, Establishment of an Epstein-Barr Virus-Determined Nuclear Antigen-Negative Human B-Cell Line From Acute Lymphoblastic Leukemia: Brief Communication, JNCI: Journal of the National Cancer Institute, Volume 59, Issue 1, July 1977, Pages 93–94, https://doi.org/10.1093/jnci/59.1.93
- Share Icon Share
Abstract
A human B-cell line designated as BALL-1 was established from the peripheral blood of a patient with acute Iymphoblastic leukemia (ALL). Neither Epstein-Barr virus (EBV) particles nor EBV-determined nuclear antigen (EBNA) was detectable. The morphologic and growth characteristics were clearly distinct from those of numerous EBV-positive Iymphoblastoid cell lines previously reported. BALL-1 cells probably originated from the donor's leukemia cells as judged from their cytogenetic, morphologic, and surface features. The BALL-1 line was the first EBNA-negative B-cell line established from ALL.